Cost-effectiveness watchdog NICE has recommended routine NHS use of two new therapies for women with advanced breast cancer – Gilead's Trodelvy and Novartis' Piqray – in England.

Hundreds of thousands more people will be sent a home-testing kit that can help to detect signs of bowel cancer, as the NHS expands its lifesaving screening programme to those aged 50 in England.

Analysis of NHS data by Prostate Cancer UK found 50,751 men were diagnosed with prostate cancer in England in 2022 compared with 48,531 diagnoses of breast cancer. The figures increased again in ...

Following entry into a commercial agreement with Bayer, NHS England is the first healthcare ... for a diagnostic test for HER2-ultralow breast cancer, now on the label of AstraZeneca and Daiichi ...

New stats from Prostate Cancer UK suggest it is now the most common cancer in England with diagnoses of the disease ...

Jan. 28, 2025 — A new study shows that asymptomatic brain metastasis is more common in stage 4 breast cancer patients than previously believed. The study suggests that doctors may need to ...

Patients in England with a form of breast cancer will be offered a new treatment after it was given the green light for NHS use. The Institute of Cancer Research, London, (ICR) – which worked on ...

Analysis of NHS data by Prostate Cancer UK found 50,751 men were diagnosed with prostate cancer in England in 2022, compared with 48,531 diagnoses of breast cancer. The figures increased again in ...

Analysis of NHS data by Prostate Cancer UK found 50,751 men were diagnosed with prostate cancer in England in 2022 compared with 48,531 diagnoses of breast cancer. The figures increased again in ...